<DOC>
	<DOCNO>NCT01837511</DOCNO>
	<brief_summary>This study aim investigate expression Melanoma-associated antigen 3 ( MAGE-A3 ) , Melanoma-associated antigen C2 ( MAGE-C2 ) , New York esophageal squamous cell carcinoma 1 ( NY-ESO-1 ) , L antigen family member 1 ( LAGE-1 ) , Wilms ' tumor gene ( WT1 ) PRAME ( PReferentially express Antigen MElanoma ) tumor antigens large number pathologically proven stage I , II III NSCLC sample Asiatic patient .</brief_summary>
	<brief_title>Analysis Incidence Expression Tumor Antigens Pathologically Proven Stage I , II III Non-Small Cell Lung Cancer ( NSCLC ) Asiatic Patients</brief_title>
	<detailed_description>This study base upon analysis sample patient-related data already available various investigation site . There study treatment study-specific procedure carry patient . Clinical data collect include patient demographic ( age , gender ) , Tumor , Node , Metastasis ( stag system ) [ TNM stage ] , histopathologic description patient smoker status . Strict anonymity patient data maintain . This retrospective study base upon analysis archive formalin-fixed paraffin-embedded tissue sample patient-related data already available investigational site .</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<criteria>For inclusion tissue sample , follow criterion must meet : The patient pathologically proven stage I , II III NSCLC . All data require available patient 's record . Many patient may longer alive , long contact investigation site . Thus , patient require give informed consent inclusion study .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2013</verification_date>
	<keyword>Tumor antigen</keyword>
	<keyword>Asiatic patient</keyword>
	<keyword>Reverse Transciptase-Polymerase chain reaction ( RT-PCR )</keyword>
	<keyword>Non-small cell lung cancer ( NSCLC )</keyword>
</DOC>